Aging Cell 23, e14138
1052 Additionally, the current market price of treatment is high, at $26,500 per person per year
On June 16, 2026, the Company hosted a virtual Key Opinion Leader event where Tim Heise, MD (Profil, Neuss, Germany) joined Olivier Soula, CEO and cofounder, and You-Ping Chan, Head of R&D, to review the Phase 3 results in type 2 diabetes
[PubMed] [Google Scholar] 202.Santhakumar R., Gayathri K., Ramalingam P.K., Manjunath B.V., Karuppusamy N., Vetriveeran B., Selvamani S., Vishnuram P., Muruganathan A., Natarajan K
Schmid R, Heuckeroth S, Korf A, Smirnov A, Myers O, Dyrlund TS, et al
Clinical trials have shown that semaglutide can lead to significant weight loss, making it an attractive option for individuals struggling to shed excess pounds